Uselessness of anti-actin antibody in celiac disease screening

Clinica Chimica Acta

Volumn 390, Issue 1-2, 2008, Pages 134-137

  Fabbro, Elisa ^a   Rubert, Laura ^a   Quaglia, Sara ^a   Ferrara, Fortunato ^a   Kiren, Valentina ^a   Ventura, Alessandro ^a   Not, Tarcisio ^a  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Anti actin antibodies; Anti transglutaminase antibodies; Celiac disease; Gut derived single chain variable fragment anti actin antibody; Intestinal damage

Indexed keywords

ACTIN ANTIBODY;

ADULT; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INTESTINE INJURY; MAJOR CLINICAL STUDY; MALE; PHAGE DISPLAY; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY;

ACTINS; ADOLESCENT; ADULT; AUTOANTIBODIES; CELIAC DISEASE; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; SENSITIVITY AND SPECIFICITY;

EID: 39649125154     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.01.015     Document Type: Article

References (25)

1. Alaedini A., and Green P. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med 142 (2005) 289-298
2. Hill I. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations?. Gastroenterology 128 (2005) S25-S32
3. Trevisiol C., Ventura A., Baldas V., et al. A reliable screening procedure for coeliac disease in clinical practice. Scand J Gastroenterol 37 (2002) 679-684
4. Tursi A., Brandimarte G., and Giorgetti G. Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol 36 (2003) 219-221
5. Clemente M., Musu M., Troncone R., et al. Enterocyte actin autoantibody detection: a new diagnostic tool in celiac disease diagnosis: results of a multicenter study. Am J Gastroenterol 99 (2004) 1551-1556
6. Carroccio A., Brusca I., Iacono G., et al. Anti-actin antibodies in celiac disease: correlation with intestinal mucosa damage and comparison of ELISA with the immunofluorescence assay. Clin Chem 51 (2005) 917-920
7. Granito A., Muratori P., Cassani F., et al. Anti-actin IgA antibodies in severe coeliac disease. Clin Exp Immunol 137 (2004) 386-392
8. Murray J., Herlein J., Mitros F., and Goeken J. Serologic testing for celiac disease in the United States: results of a multilaboratory comparison study. Clin Diagn Lab Immunol 7 (2000) 584-587
9. Carroccio A., Brusca I., Iacono G., et al. IgA anti-actin antibodies ELISA in coeliac disease: a multicentre study. Dig Liv Dis 39 (2007) 818-823
10. Niveloni S., Sugal E., Cabanne A., et al. Antibodies against synthetic deaminated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease. Clin Chem 53 (2007) 2186-2192
11. Cancado E., Abrantes-Lemos C., Vilas-Boas L., Novo N., Carrilho F., and Laudanna A. Thermolabile and calcium-dependent serum factor interferes with polymerized actin, and impairs anti-actin antibody detection. J Autoimmun 17 (2001) 223-228
12. Dos Remedios C., Chhabra D., Kekic M., et al. Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol Rev 83 (2003) 433-473
13. Working Group of European Society of Pediatric Gastroenterology and Nutrition. Revised criteria for diagnosis of coeliac disease. Arch Dis Child 65 (1990) 909-911
14. Oberhuber G., Granditsch G., and Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologist. Eur J Gastroenterol Hepatol 11 (1999) 1185-1194
15. Hyams J., Ferry G., Mandel F., et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 12 (1991) 439-447
16. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 298 (1989) 82-86
17. Marzari R., Sblattero D., Florian F., et al. Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J Immunol 166 (2001) 4170-4176
18. Marks J.D., Hoogenboom H.R., Bonnert T.P., McCafferty J., Griffiths A.D., Winter G., et al. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 222 (1991) 581-597
19. Sblattero D., Berti I., Trevisiol C., et al. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol 95 (2000) 1253-1257
20. Zeissig S., Bojarski C., Buergel N., et al. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut 53 (2004) 1295-1302
21. Margutti P., Delunardo F., Sorice M., et al. Screening of a HUAEC cDNA library identifies actin as a candidate autoantigen associated with carotid atherosclerosis. Clin Exp Immunol 137 (2004) 209-215
22. Clemente M., De Virgilis S., Kang J., et al. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 52 (2003) 218-223
23. Clemente M., Musu M., Frau F., et al. Immune reaction against the cytoskeleton in coeliac disease. Gut 47 (2000) 520-526
24. Dolfini E., Roncoroni L., Elli L., et al. Cytoskeleton reorganization and ultrastructural damage induced by gliadin in a three-dimensional in vitro model. World J Gastroenterol 11 (2005) 7597-7601
25. Huang Y., Seguro K., Motoki M., and Tawada K. Cross-linking of contractile proteins from skeletal muscle by treatment with microbial transglutaminase. J Biochem (Tokyo) 112 (1992) 229-234